Celiac disease was not discovered in a single moment but recognized in stages over roughly two thousand years, from vague ancient descriptions of chronic digestive wasting to the precise identification of gluten as the culprit in 1953. The illness likely existed long before anyone wrote about it, emerging alongside the birth of agriculture itself. Its history is a story of slow-moving medical detective work, where each generation added a piece and the full picture did not come together until well into the twentieth century.
A Disease as Old as Farming
The roots of celiac disease reach back to the dawn of grain cultivation. Archaeological and genetic evidence from the Fertile Crescent, particularly the Göbekli Tepe region in modern-day Turkey, suggests that celiac disease probably emerged as humans shifted from hunting and gathering to farming wheat and other grains thousands of years ago.1PubMed Central. Celiac disease: a disorder emerging from antiquity, its evolving classification and risk, and potential new treatment paradigms Before agriculture, human diets contained little to no gluten. Once wheat became a dietary staple, individuals whose immune systems reacted to gluten proteins began suffering consequences they had no framework to understand.
An evolutionary wrinkle makes this history even more interesting. Researchers have found that wheat consumption and the genetic markers most strongly linked to celiac disease, known as HLA-DQ2 and HLA-DQ8, tend to cluster together geographically. One theory holds that celiac disease is actually more common in populations that adopted wheat farming later, because those groups had less time for natural selection to weed out the disease-predisposing genes.2PubMed. Co-localization of gluten consumption and HLA-DQ2 and -DQ8 genotypes, a clue to the history of celiac disease The competing explanation is that positive selection actually favored HLA-DQ2 genes in wheat-consuming areas for other immune benefits, even though those same genes carried the trade-off of celiac susceptibility. Either way, the disease and the grain have been tangled together from the start.
The First Written Accounts
The earliest known medical description of something resembling celiac disease came from Aretaeus of Cappadocia, a Greek physician who practiced in the first or second century CE. Aretaeus wrote about a condition he called “koiliakos,” derived from the Greek word for abdomen, describing patients with chronic diarrhea, malabsorption, and wasting. His accounts were remarkably detailed for the era, noting that the illness was prolonged, resistant to treatment, and prone to relapse. Aretaeus did not connect the condition to diet, but his clinical portrait was accurate enough that later physicians could recognize the same disease in their own patients.
For the next seventeen centuries, celiac disease essentially disappeared from the medical literature. Patients certainly continued to suffer, but without a clear diagnostic framework, their symptoms were lumped together with other chronic gastrointestinal complaints or attributed to vague constitutional weakness.
Samuel Gee and the Modern Clinical Description
The modern medical history of celiac disease begins in 1888 with Samuel Gee, a British pediatrician at St Bartholomew’s Hospital in London. Gee delivered a landmark lecture titled “On the Coeliac Affection,” in which he described the disease in children with striking precision. He noted the chronic indigestion, the pale and foul-smelling stools, the wasted muscles, and the distended bellies. Gee drew an explicit connection back to Aretaeus, recognizing that the ancient Greek had described the same condition.3PubMed Central. Samuel Gee, Aretaeus, and the coeliac affection
Gee made another observation that turned out to be prophetic: he suspected that diet held the key to managing the illness. He wrote that “if the patient can be cured at all, it must be by means of diet,” though he could not specify which foods were the problem. His instinct was correct, but the field would spend decades groping toward the answer through trial and error.
The Banana Diet and Other Early Experiments
In the early twentieth century, clinicians tried all sorts of dietary regimens for children with celiac disease. One of the more famous attempts was the “banana diet,” championed by American physician Sidney Haas in the 1920s. Haas observed that children with celiac disease improved dramatically when put on a diet consisting largely of bananas, and he published his results in 1924.4American Journal of Diseases of Children. The Value of the Banana in the Treatment of Celiac Disease The banana diet gained widespread popularity and was used for decades. It worked, though not for the reason Haas believed. The bananas were not curative; rather, a diet heavy on bananas simply happened to exclude wheat and other gluten-containing grains. Haas never accepted the gluten explanation, even after it was proven.
Other clinicians experimented with eliminating fats, restricting starches, or prescribing specific combinations of foods. None of these approaches was based on an understanding of the underlying cause, and their success depended mostly on how thoroughly they happened to remove gluten from the patient’s plate.
Willem Dicke and the Wartime Clue
The breakthrough that changed everything came from a Dutch pediatrician named Willem Karel Dicke. During the 1930s, Dicke began noticing that certain children with celiac disease worsened when they ate bread and improved when bread was removed from their diet. He gathered clinical observations and listened carefully to parents who reported the same pattern.5PubMed Central. The Power of Observation in Advancing Celiac Disease This was years before he had any proof, and the idea that bread, a dietary staple, could be poisoning children was not an easy sell to the medical establishment.
The story that looms largest in popular retellings is the Dutch famine of 1944–1945, known as the Hongerwinter. During the German occupation of the Netherlands, grain supplies were cut off and bread became scarce. Dicke observed that children with celiac disease paradoxically improved during the famine, only to relapse when bread became available again after liberation. This dramatic natural experiment reinforced what Dicke had suspected for years. Through clinical observations of his child patients and years of questioning families about dietary patterns, he concluded that wheat-based foods were toxic to people with celiac disease.6PubMed Central. Willem Dicke. Brilliant clinical observer and translational investigator. Discoverer of the toxic cause of celiac disease
Dicke’s suspicions were confirmed scientifically in 1953, when he collaborated with biochemists J.H. van de Kamer and H.A. Weijers. Together, they identified gluten, the protein fraction found in wheat, barley, and rye, as the specific component responsible for the intestinal damage.7PubMed. Discovery of gluten as the injurious component in celiac disease This was the moment the disease finally had a cause, and the gluten-free diet became the definitive treatment.
Seeing the Damage Under a Microscope
Knowing that gluten caused celiac disease was a huge step, but doctors still needed a way to confirm the diagnosis by looking at what was happening inside the body. A major advance came with the Crosby capsule, a small device that could be swallowed by a patient and used to snip a tiny sample of tissue from the lining of the small intestine without surgery. Introduced in the late 1950s, this tool transformed celiac diagnosis by giving clinicians their first routine look at the intestinal damage the disease caused.8PubMed. Small bowel endoscopy and coeliac disease
What pathologists found under the microscope was distinctive: the tiny finger-like projections lining the small intestine, called villi, were flattened or destroyed in celiac patients. This villous atrophy explained the malabsorption that had been described since antiquity. Without intact villi, the gut could not properly absorb nutrients from food, leading to the diarrhea, weight loss, and nutritional deficiencies that defined the disease.
In 1992, pathologist Michael Marsh proposed a classification system that organized the spectrum of intestinal changes seen in celiac disease into progressive stages, from early immune-cell infiltration in an otherwise normal-looking mucosa to the complete flattening of the villi seen in advanced cases.9PubMed Central. Mucosal histopathology in celiac disease: a rebuttal of Oberhuber’s sub-division of Marsh III The Marsh classification remains a cornerstone of diagnosis, though it has been debated and modified over the decades. Intestinal biopsy interpreted through this framework is still considered the gold standard for confirming celiac disease.10PubMed Central. Diagnosing celiac disease: A critical overview
Genetics and the Immune System Come Into Focus
By the 1970s and 1980s, researchers had established that celiac disease ran in families, and the search for the genetic basis intensified. The critical finding was that virtually all celiac patients carry one or both of two specific immune-system gene variants, HLA-DQ2 and HLA-DQ8. These genes encode molecules that present fragments of gluten to the immune system in a way that triggers an inflammatory attack on the intestinal lining.11PubMed. HLA in coeliac disease: unravelling the complex genetics of a complex disorder Carrying these genes is necessary but not sufficient for developing celiac disease. Roughly a third of people of European descent carry HLA-DQ2 or DQ8, yet only a small fraction ever develop the condition, indicating that other genetic and environmental factors are involved.
A landmark discovery in 1997 identified the specific protein the immune system targets in celiac disease. Researchers found that tissue transglutaminase, an enzyme present throughout the body, is the autoantigen, meaning the immune system of celiac patients produces antibodies against it.12PubMed. Identification of tissue transglutaminase as the autoantigen of celiac disease This discovery confirmed that celiac disease is genuinely autoimmune, not just an allergy or intolerance, and it revolutionized diagnosis. Blood tests measuring antibodies against tissue transglutaminase became the primary screening tool, replacing the need for biopsy as the first step in many clinical settings.13PubMed Central. Tissue transglutaminase as the autoantigen of coeliac disease
From Rare Childhood Disease to Common Adult Condition
For most of its modern medical history, celiac disease was considered rare and almost exclusively a childhood illness. Textbooks through much of the twentieth century described the classic presentation: a malnourished toddler with a bloated belly and failure to thrive. This picture was not wrong, but it was severely incomplete.
The availability of antibody blood tests in the 1990s and 2000s changed perception dramatically. Large screening studies revealed that celiac disease was far more common than anyone had thought, and that it frequently appeared in adults who had never been diagnosed in childhood. A global meta-analysis of screening data found a pooled seroprevalence of about 1.4% worldwide, with biopsy-confirmed celiac disease found in roughly 0.7% of people screened.14PubMed. Global Prevalence of Celiac Disease: Systematic Review and Meta-analysis These numbers mean that for every diagnosed patient, several more go undetected, often for years or decades. The realization that celiac disease affects adults as often as children, and can present with symptoms far beyond the classic gastrointestinal picture, including anemia, bone loss, fatigue, and neurological complaints, was one of the most important shifts in the disease’s history.
Conditions That Muddied the Waters
One reason celiac disease took so long to understand is that other conditions produce strikingly similar symptoms. Tropical sprue, a malabsorptive disorder found in equatorial regions, causes chronic diarrhea, villous atrophy, and nutritional deficiencies that can look identical to celiac disease on biopsy. A systematic review found that there was no difference between the two conditions in the prevalence of chronic diarrhea, abdominal distension, weight loss, or the degree of intestinal inflammation. The only reliable way to tell them apart is celiac-specific blood tests.15PubMed. Clinical, endoscopic, and histological differentiation between celiac disease and tropical sprue: A systematic review In regions where both diseases occur, misdiagnosis remains a real problem.
Dermatitis herpetiformis, a skin condition that causes intensely itchy blisters typically on the elbows, knees, and buttocks, is another piece of the celiac puzzle that took time to fit into place. First described in the late 1800s, it was not recognized as a manifestation of celiac disease until the 1960s and 1970s, when researchers demonstrated that patients with the rash had the same intestinal damage as those with classic celiac symptoms, even when they had no digestive complaints at all.16PubMed Central. Dermatitis Herpetiformis: An Update on Diagnosis and Management Like intestinal celiac disease, dermatitis herpetiformis responds to a gluten-free diet.
The Rise of Gluten-Free Regulation
Once gluten was identified as the trigger, the gluten-free diet became the only effective treatment, and it remains so today. But defining “gluten-free” for commercial food labeling took decades of regulatory work. Different countries and international bodies eventually converged on a threshold: most major jurisdictions, including the United States, the European Union, the United Kingdom, and Canada, define gluten-free foods as those containing less than 20 parts per million of gluten.17PubMed. Oats in Gluten-Free Diets: An Examination of the Codex Standard and Country-Specific Differences in Gluten-Free-Food Labeling Regulations, for Oats and Oats Declared as Ingredients in Gluten-Free Products This standard is based on the Codex Alimentarius, the food-standards body run by the World Health Organization and the Food and Agriculture Organization. Australia and New Zealand stand out for maintaining a stricter standard. Oats remain a special case: they do not naturally contain the same gluten proteins as wheat, barley, or rye, but cross-contamination during farming and processing is common, and regulations around oats in gluten-free products vary by country.
When the Diet Does Not Work
For the vast majority of celiac patients, a strict gluten-free diet resolves symptoms and allows the intestinal lining to heal. But a small subset does not improve, even with careful dietary adherence. This condition, known as refractory celiac disease, comes in two forms. Type I behaves like stubborn celiac disease and generally responds to immune-suppressing medications. Type II is far more serious. It involves the accumulation of abnormal immune cells in the intestinal lining that have characteristics of a low-grade lymphoma.18PubMed. Refractory celiac disease: from bench to bedside
Research has shown that these abnormal cells can be found in up to three-quarters of patients with refractory celiac disease, and their presence is a marker of poor outcome, including the risk of progressing to an aggressive intestinal cancer called enteropathy-associated T-cell lymphoma.19The Lancet. Aberrant clonal intraepithelial T lymphocytes in refractory celiac disease The recognition that refractory celiac disease may represent a bridge between celiac disease and lymphoma was one of the more sobering discoveries in the field’s recent history, and it underscores why diagnosis and lifelong dietary management matter.
The Search for Treatments Beyond Diet
Living gluten-free is effective but demanding, and accidental gluten exposure is hard to avoid entirely. This reality has driven a growing effort to develop therapies that would supplement or even replace the diet. Researchers are pursuing several approaches: enzymes that break down gluten in the gut before it can trigger an immune response, drugs that tighten the intestinal barrier to prevent gluten fragments from slipping through, medications that dampen the specific immune pathways involved in the disease, and strategies that aim to retrain the immune system to tolerate gluten altogether.20PubMed Central. New Insights into Non-Dietary Treatment in Celiac Disease: Emerging Therapeutic Options
None of these approaches has yet reached the point of replacing the gluten-free diet, but several are in clinical trials. For the roughly one percent of the global population affected by celiac disease, a treatment that protects against accidental exposure or allows some degree of normal eating would be transformative. The disease that Aretaeus described two millennia ago as an intractable wasting illness may, within the coming decades, become one that can be managed with something more than avoidance alone.